Efficacy and risk of harms of repeat ivermectin mass drug administrations for control of malaria (RIMDAMAL): a cluster-randomised trial (Q64117418)

From Wikidata
Jump to navigation Jump to search
scholarly article by Brian D Foy et al published 13 April 2019 in The Lancet
edit
Language Label Description Also known as
English
Efficacy and risk of harms of repeat ivermectin mass drug administrations for control of malaria (RIMDAMAL): a cluster-randomised trial
scholarly article by Brian D Foy et al published 13 April 2019 in The Lancet

    Statements

    Efficacy and risk of harms of repeat ivermectin mass drug administrations for control of malaria (RIMDAMAL): a cluster-randomised trial (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    Brian D Foy
    0 references
    Jonathan A Seaman
    0 references
    Sangeeta Rao
    0 references
    Martina Wade
    0 references
    Sunil Parikh
    0 references
    Dieudonné D Soma
    0 references
    André B Sagna
    0 references
    Florence Fournet
    0 references
    Hannah C Slater
    0 references
    Roland Bougma
    0 references
    François Drabo
    0 references
    A Gafar V Coulidiaty
    0 references
    Nöel Rouamba
    0 references
    13 April 2019
    0 references
    0 references
    393
    0 references
    10180
    0 references
    1517-1526
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit